Atossa Genetics to Present at The MicroCap Conference in New York City on October 5, 2017
September 29 2017 - 8:00AM
Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical
company developing novel therapeutics and delivery methods for
breast cancer and other breast conditions, today announced that
Kyle Guse, CFO, will be a featured presenter at The MicroCap
Conference on Thursday October 5, 2017 at 12:30 PM Eastern Time.
The conference is being held at the Essex House in New York City.
Mr. Guse will also be available for one-on-one meetings with the
investment community.
About Atossa Genetics
Atossa Genetics Inc., is a clinical-stage pharmaceutical company
developing novel therapeutics and delivery methods to treat breast
cancer and other breast conditions. For more information, please
visit www.atossagenetics.com.
Forward-Looking Statements
Forward-looking statements in this press release, which Atossa
undertakes no obligation to update, are subject to risks and
uncertainties that may cause actual results to differ materially
from the anticipated or estimated future results, including the
risks and uncertainties associated with actions and inactions by
the FDA, the outcome or timing of regulatory approvals needed by
Atossa, lower than anticipated rate of patient enrollment, results
of clinical studies, the safety and efficacy of Atossa's products
and services, performance of clinical research organizations and
investigators, obstacles resulting from proprietary rights held by
others, such as patent rights, and other risks detailed from time
to time in Atossa's filings with the Securities and Exchange
Commission, including without limitation its periodic reports on
Form 10-K and 10-Q, each as amended and supplemented from time to
time.
Atossa Genetics Company Contact:
Atossa Genetics Inc.Kyle GuseCFO and General Counsel866
893-4927kyle.guse@atossagenetics.com
Investor Relations Contact
Scott GordonCorProminence LLC377 Oak StreetConcourse 2Garden
City, NY 11530Office: 516.222.2560scottg@corprominence.com
Atossa Therapeutics (NASDAQ:ATOS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Atossa Therapeutics (NASDAQ:ATOS)
Historical Stock Chart
From Apr 2023 to Apr 2024